Adaptogenics Appoints Accomplished Peptide Scientist Dr. J. David Warren as Chief Executive Officer #Cosmetics #Makeup #Appointment #CSEStocks #SmallCaps #Investing
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics" or the "Company") is pleased to announce the appointment of J. David Warren, Ph.D., as Chief Executive Officer and as a director of the Company, effective October 1st, 2026.Dr. Warren brings more than two decades of experience in bioorganic chemistry, medicinal chemistry, peptide science and translational drug discovery. He is an Adjunct Associate Professor of Research in...
http://dlvr.it/TVlMLg
http://dlvr.it/TVlMLg
Comments
Post a Comment